Red Yeast Pigment Reversed Nanoplastic-Worsened Asthma in Mice via Gut Repair

If you've ever eyed a plastic takeout container and wondered whether the flecks of plastic it sheds could be feeding a health problem you already have, a new mouse study gives that suspicion some molecular backing. Researchers in China found that polystyrene nanoplastics, the near-invisible fragments that flake off food packaging, made allergic asthma dramatically worse in mice, in part by damaging the gut lining. The same team also identified a compound that reversed much of that damage: a red yeast pigment called torularhodin. Published in the Journal of Future Foods, the study traces a chain of cause and effect from packaging, to gut bacteria, to inflamed lungs, one measurable step at a time, in mice.

Key takeaways

• Mice exposed to polystyrene nanoplastics (PS-NPs, plastic fragments smaller than one micrometer) on top of an asthma trigger developed markedly worse airway inflammation, breathing resistance, and gut barrier damage than mice given the asthma trigger alone.
• Torularhodin, a carotenoid pigment extracted from red yeast, reduced airway inflammation, calmed an inflammatory signaling pathway called PLA2/TRPV1, and restored gut barrier proteins in the mice, with the higher of two tested doses (20 mg/kg) outperforming the lower one.
• The gut-lung axis, the biological communication line between gut bacteria and lung immune activity, appeared to be part of how nanoplastics worsened asthma in these mice, not just direct contact with the airways.
• This is one mouse study from one lab, not yet replicated or tested in humans, so torularhodin is not an established treatment for asthma and nothing here is medical advice.

Polystyrene Nanoplastics Worsened Allergic Asthma in Mice

Researchers exposed mice to polystyrene nanoplastics (PS-NPs), 20-nanometer plastic particles used as a stand-in for the nanoplastics shed by disposable food containers and foam packaging, then layered that exposure on top of a standard allergic asthma model. In the study, 147 male mice received an egg-protein allergen called ovalbumin to trigger asthma-like inflammation, and a subset also received daily intranasal PS-NPs at 40 micrograms per kilogram of body weight for four weeks. Mice given both the allergen and the nanoplastics developed markedly worse airway wall thickening, mucus buildup, and collagen deposits in lung tissue than mice given the allergen alone.

Red Yeast Compound Calmed the Nanoplastic-Driven Reaction in Mice

Torularhodin, a carotenoid (a plant and microbial pigment with antioxidant properties) extracted from red yeast, reversed much of that damage when given by mouth every other day for the same four weeks. At a dose of 20 milligrams per kilogram, the compound reduced airway inflammation, restored lung tissue structure, and cut markers of oxidative stress including reactive oxygen species and malondialdehyde, while boosting glutathione, the body's primary antioxidant buffer. A lower dose of 2 milligrams per kilogram produced the same pattern of improvement but to a smaller degree, indicating a dose-dependent effect.

Why This Matters if Your Asthma Seems to Track Your Gut

Asthma remains one of the most common chronic respiratory diseases worldwide, and standard treatments like inhaled corticosteroids target airway inflammation directly but do little for the gut side of the equation, where microbiota-derived compounds also shape immune tone. This study adds to a growing body of evidence, summarized in a 2021 Science review on microplastics and human health, that nanoplastics are now routinely detected in food, drinking water, and packaging materials. If the mechanism identified here, plastics disrupting the gut barrier and triggering downstream lung inflammation, holds up in further research, it would suggest that some flares in allergic asthma might have a dietary or environmental plastic-exposure component worth discussing with a doctor.

How the Researchers Traced Plastic to Gut to Lung in Mice

The study's credibility rests on its layered design rather than a single measurement. The team used seven treatment groups, including a saline control, an asthma-only group, an asthma-plus-nanoplastics group, and dose-matched torularhodin groups, alongside two positive controls: vitamin E and capsazepine (a drug that blocks the TRPV1 nerve receptor implicated in the inflammation pathway). Beyond lung pathology and pulmonary function testing, the researchers sequenced gut bacteria and ran untargeted metabolomics on lung tissue, identifying 281 metabolites that differed significantly between the nanoplastic-exposed mice and the high-dose torularhodin group, a combination described in the gut-lung axis literature on asthma as key to establishing a mechanism rather than just an association.

What the Gut Bacteria Changes Looked Like in the Mice

Torularhodin treatment increased two specific bacterial groups, Lachnospiraceae_UCG-006 and Limosilactobacillus, both linked to gut barrier maintenance, while the untreated nanoplastic-exposed mice were dominated by different taxa, including Akkermansia and Muribaculum. The torularhodin-treated mice also showed restored levels of ZO-1 and occludin, two proteins that hold the gut lining's cells tightly together, alongside lower levels of TLR4, an immune receptor triggered when gut permeability rises and bacterial byproducts leak into circulation.

What Remains Unproven

This is animal research from a single laboratory, and none of it has been independently replicated. The mice received PS-NPs by nasal instillation rather than through the mouth, so it does not directly model how humans would actually encounter nanoplastics from food packaging, mainly through eating and drinking. The authors calculated that their dose corresponds to roughly 194 micrograms per day for a 60-kilogram adult, which they note may fall within the lower-to-moderate range of estimated human exposure, but that conversion carries its own uncertainty. The study also lacked a clinically established asthma drug, such as an inhaled steroid, as a comparison.

What Comes Next

The research team has flagged specific next steps: testing oral, rather than nasal, nanoplastic exposure to better mirror real dietary intake, running fecal microbiota transplant experiments to test whether the gut bacteria changes are actually driving the lung improvements, and comparing torularhodin against standard asthma medications rather than mechanistic controls. None of that work has a stated timeline yet, and none of it has moved into human volunteers.

Common Questions

Does this mean plastic food packaging causes asthma in humans? No. This study was conducted entirely in mice, and while nanoplastics are known to be present in human food and water, no human trial has tested whether they worsen asthma or whether torularhodin would help.

What is torularhodin? It's a carotenoid pigment, a class of antioxidant compounds also found in carrots and tomatoes, that in this case was extracted from red yeast. It's already studied as a food-derived antioxidant, but has not been established as an asthma treatment.

Should I take a torularhodin supplement for asthma or allergies? Not based on this study. The doses tested were designed for mice, no human safety or efficacy data exist for this use, and asthma should continue to be managed with your doctor's guidance.

What is the gut-lung axis? It's the idea that gut bacteria and their byproducts can influence immune activity in the lungs, and vice versa, via shared circulation and immune signaling, rather than the gut and lungs functioning as fully separate systems.

References

1. Xin Zeng, Zhenjie Lu, Wanjia Lv, et al. (2026). Torularhodin Attenuates Allergic Asthma Aggravated by Nanoplastics by Modulating the Gut-Lung Axis and PLA2/TRPV1-NF-κB Pathway. Journal of Future Foods. https://doi.org/10.1016/j.jfutfo.2026.08.005
2. Journal of Future Foods, primary study. sciencedirect.com. https://www.sciencedirect.com/science/article/pii/S2772566926002338